Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ASTeX Announces Record Fiscal 1998 Third Quarter Earnings; Reports All-Time Record Quarterly Revenues and Earnings.


WOBURN Woburn, village, England
Woburn (w`bərn), village, Bedfordshire, S central England.
, Mass.--(BUSINESS WIRE)--April 28, 1998--Applied Science and Technology, Inc. ("ASTeX") (Nasdaq: ASTX) today reported record financial results for the fiscal 1998 third quarter and nine months ended March 28, 1998.

Total revenue for the third quarter of fiscal 1998 was an all-time all-time
adj.
Exceeding all others up to the present time: an all-time speed skating record.


all-time
Adjective

Informal
 record $23.5 million, an increase of 113% versus $11.0 million for the third quarter of fiscal 1997. Excluding the recently acquired ASTeX Sorbios and ASTeX CPI (1) (Characters Per Inch) The measurement of the density of characters per inch on tape or paper. A printer's CPI button switches character pitch.

(2) (Counts Per I
, which were not included in the comparable quarter of 1997, total revenue for the third quarter of fiscal 1998 was $18.0 million, an increase of 63% versus the prior year. Net earnings for the quarter grew to an all-time record $1.6 million, or $0.18 per share diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
, compared to net earnings of $390,000, or $0.06 per share diluted, in last year's comparable quarter.

Total revenue for the nine months ended March 28, 1998, was $63.3 million, an increase of 110% versus $30.2 million for the nine months of fiscal 1997. Net earnings for the nine months rose to $4.0 million, or $0.47 per share diluted, compared to $982,000, or $0.15 per share diluted, in the previous year.

Dr. Richard Ri·chard   , Joseph Henri Maurice Known as "Rocket." 1921-2000.

Canadian hockey player. A right wing for the Montreal Canadiens (1942-1960), he led his team to eight Stanley Cup championships and was the first player to score 50 goals in a
 Post, President and Chief Executive Officer, commented, "Our record operating results for the quarter reflect increasing market penetration Noun 1. market penetration - the extent to which a product is recognized and bought by customers in a particular market
penetration - the act of entering into or through something; "the penetration of upper management by women"
 and our diverse markets. Demand for RF products for high-density high-den·si·ty
adj.
Having a high concentration: high-density urban areas. 
 plasma CVD CVD Cardiovascular disease, see there  and oxide oxide, chemical compound containing oxygen and one other chemical element. Oxides are widely and abundantly distributed in nature. Water is the oxide of hydrogen. Silicon dioxide is the major component of sand and quartz.  etch To create a design in a material by digging out the material. The circuit designs on printed circuit boards and chips are etched by acid. See chip and printed circuit board.  applications has been strong, offsetting a decline in demand for our microwave and ozone equipment for semiconductor production related to the semiconductor equipment industry slowdown For articles with similar titles, see Slow Down (disambiguation).
A slowdown is an industrial action in which employees perform their duties but seek to reduce productivity or efficiency in their performance of these duties.
. We successfully executed a production ramp of RF products to meet customer demand, and this revenue increased 75% over the second quarter of fiscal 1998. Our record results also benefited from the strength of sales in non-semiconductor markets, including medical, electro-optic Refers to the effects electricity has on optical materials such as a change in refraction or birefringence. The term was coined before "optoelectronic," but both terms are often used synonymously. See refraction, birefringent, photonics, optoelectronic and integrated optics.  and synthetic diamond Synthetic diamond, also called lab-created, manufactured, "lab-grown" or cultured diamond is a term used to describe diamond (the tetrahedral carbon allotrope) which has been produced by a technological process, as opposed to natural diamond, which is , which comprised 37% of total revenues, an increase from 32% in the previous quarter. This increase was the result of strong demand for DC switching power supplies Switch´ing power supply

n. 1. a device used as part of an electronic device, which transforms electrical current from an AC line circuit to DC for use in electronic devices, and which can use either 110 volt or 220 volt AC line curent.
 for pulsed lasers used in dermatology dermatology (dûrmətŏl`əjē), branch of medicine concerned with diagnosis and treatment of diseases and disorders of the skin.  applications, RF generators for medical applications, and plasma equipment for advanced industrial production applications."

"We see expanded acceptance of ASTRON ASTRON Astronomy , our new product for chamber clean applications. The Company anticipates strong demand for our SmartPower microwave generator generator, in electricity, machine used to change mechanical energy into electrical energy. It operates on the principle of electromagnetic induction, discovered (1831) by Michael Faraday.  products due to their advanced features and superior price performance. ASTeX will begin shipping them to customers in Q4.

We will announce the LIQUOZONE 100 ozonated liquid delivery tool at Semicon West in July July: see month. . In the area of specialty power supplies, we introduced new RF MRI 1. (application) MRI - Magnetic Resonance Imaging.
2. MRI - Measurement Requirements and Interface.
 amplifiers, establishing improved price performance for the MRI industry, and new laser power supplies. These products are aimed at continuing and expanding ASTeX's market leadership."

"Continuing to strengthen our infrastructure and management," Dr. Post continued, "we have recently hired Avishay Katz Katz , Bernard 1911-2003.

German-born British physiologist. He shared a 1970 Nobel Prize for the study of nerve impulse transmission.
 and Jill E. Maunder. Dr. Katz, Senior Vice President, Global Customer Operations, has extensive electronics industry experience, most recently as Vice President and Chief Technical Officer at Watkins-Johnson, and previously in management positions with AT&T-Bell Laboratories and EPRI EPRI Electric Power Research Institute
EPRI European Parliaments Research Initiatives
. Ms. Maunder, Vice President of Human Resources The fancy word for "people." The human resources department within an organization, years ago known as the "personnel department," manages the administrative aspects of the employees. , joins ASTeX from Outsourcing (1) Contracting with outside consultants, software houses or service bureaus to perform systems analysis, programming and datacenter operations. Contrast with insourcing. See netsourcing, ASP, SSP and facilities management.  Solutions, Inc. where she was co-founder and President and previously in human resources positions at Bull HN Information Systems, Gen Rad, Inc. and Commercial Union Assurance Company."

"We continue to invest in the integration of the Company's manufacturing sites and management systems. During the quarter we began installation of a new Enterprise Resource Planning See ERP.

(application, business) Enterprise Resource Planning - (ERP) Any software system designed to support and automate the business processes of medium and large businesses.
 computer system which we plan to implement at two sites by the end of fiscal 1998, and company-wide in fiscal 1999. Furthermore, we continue toward our goal of having ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9001 registered facilities by the end of 1998," stated Dr. Post.

"As we look into the near future, we expect revenues from new products related to technology buys and from non-semiconductor markets to continue the strength shown in the third quarter. However, we expect a further decline in revenues from products that are primarily related to semiconductor fab See fab.  capacity as our customers further reduce inventory. These factors may result in a 5%-10% sequential One after the other in some consecutive order such as by name or number.  decline in Q4 revenues. Based on the revenue and product mix outlook for the fourth quarter, we expect gross margins may decline and fourth quarter net income may decline sequentially se·quen·tial  
adj.
1. Forming or characterized by a sequence, as of units or musical notes.

2. Sequent.



se·quen
 approximately 50% despite expense control measures that have been implemented."

Dr. Post concluded, "We are very pleased with the progress we have made in offering innovative solutions to our customers. We have made significant progress toward integration of our internal resources. Through the relationships between ASTeX and its customers, we have introduced several new product lines which have increased our market share. Consequently, we believe we are in a position to take advantage of significant growth opportunities in the future."

ASTeX is a leading provider of innovative production technology for the manufacture of advanced semiconductor devices. ASTeX markets its plasma sources Plasma sources generate plasmas.

Excitation of a plasma requires partial ionisation of neutral atoms and/or molecules of a medium. There are several ways to cause ionisation: collisions of energetic particles, strong electric fields acting on bond electrons, or ionising
 and subsystems, ozone generators and subsystems, and specialty power sources to the world's leading semiconductor capital equipment manufacturers. ASTeX markets the same underlying core technology for medical, electro-optic and synthetic diamond applications. For more information, visit the new ASTeX web site at www.astex.com. -0-

"Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995: This release contains forward looking statements that are subject to risks and uncertainties, including, but not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. -0-
         Applied Science and Technology, Inc. and Subsidiaries
                 Consolidated Statements of Operations

                                                Three Months Ended
                                             March 28,     March 29,
                                               1998          1997
                                           (unaudited)   (unaudited)
Product sales, net                       $ 22,195,896   $ 10,123,941
Research contract
  revenue                                     293,503        247,332
Other revenue                                 972,437        641,259
     Total revenue                         23,461,836     11,012,532

Cost of sales and revenue:
     Product sales and other
       revenue                             15,076,802      6,995,463
     Research contracts                       177,617        130,733
        Total cost of sales and revenue    15,254,419      7,126,196

        Gross profit                        8,207,417      3,886,336

Operating expenses:
     Selling expenses                       1,145,261        605,724
     General and administrative
      expenses                              1,791,298        886,740
     Research and development
      expenses                              3,019,286      1,735,389
     Acquisition-related expenses                   0              0

        Total operating
         expenses                           5,955,845      3,227,853

        Earnings from
         operations                         2,251,572        658,483

Other expense (income):
     Interest expense                              36        138,200
     Interest income                         (157,522)       (99,126)
      Other expense (income)                  (37,463)          (990)
        Total other (income) expense         (194,949)        38,084

        Earnings before
         income taxes                       2,446,521        620,399

Income tax expense                            869,000        230,000

        Net earnings                     $  1,577,521   $    390,399

Basic net
 earnings per share                      $       0.19   $       0.06

Diluted net
 earnings per share                      $       0.18   $       0.06

Weighted average common shares
  outstanding used to calculate
    basic earnings per share                8,482,518      6,671,963

Weighted average common shares
  outstanding used to calculate
   diluted earnings per share               8,922,323      6,793,079
-0-
                                              Nine Months Ended
                                            March 28,    March 29,
                                              1998          1997
                                          (unaudited)   (unaudited)

Product sales, net                       $ 59,506,344   $ 27,120,927
Research contract
  revenue                                     693,923        791,562
Other revenue                               3,122,666      2,253,159
     Total revenue                         63,322,933     30,165,648

Cost of sales and revenue:
     Product sales and other
       revenue                             40,111,450     18,681,827
     Research contracts                       300,230        388,676
        Total cost of sales and revenue    40,411,680     19,070,503

        Gross profit                       22,911,253     11,095,145

Operating expenses:
     Selling expenses                       3,162,060      2,004,572
     General and administrative
      expenses                              5,078,619      2,620,667
     Research and development
      expenses                              8,430,544      4,814,654
     Acquisition-related
      expenses                                212,423              0

        Total operating
         expenses                          16,883,646      9,439,893

        Earnings from
         operations                         6,027,607      1,655,252

Other expense (income):
     Interest expense                         196,068        431,622
     Interest income                         (380,947)      (313,608)
      Other expense (income)                 (252,820)       (21,665)
        Total other (income) expense         (437,699)        96,349

        Earnings before
         income taxes                       6,465,308      1,558,903

Income tax expense                          2,458,000        577,000

        Net earnings                     $  4,007,306   $    981,903

Basic net
 earnings per share                      $       0.51   $       0.15

Diluted net
 earnings per share                      $       0.47   $       0.15

Weighted average common shares
  outstanding used to calculate
    basic earnings per share                7,874,262      6,670,166

Weighted average common shares
  outstanding used to calculate
   diluted earnings per share               8,455,678      6,737,677
-0-

         Applied Science and Technology, Inc. and Subsidiaries
                      Consolidated Balance Sheets

Assets                                      March 28,   June 28,
                                              1998        1997
                                          (unaudited)
Current assets:
     Cash and cash equivalents           $  6,647,058 $  3,246,337
     Short-term marketable investments      1,299,884            0
     Accounts receivable, trade, net       13,101,423   11,915,919
     Inventories                           15,858,422   10,013,422
     Prepaid expenses and other assets        507,568      276,682
     Deferred income taxes                  1,389,945      895,237
              Total current assets         38,804,300   26,347,597

Property, plant and equipment:
     Land                                     473,000      473,000
     Building and improvements              1,625,360    1,621,469
     Equipment                             10,141,769    7,871,718
     Furniture and fixtures                   968,577      741,143
     Leasehold improvements                 2,093,540    1,946,800
                                           15,302,246   12,654,130
     Less accumulated depreciation
      and amortization                     (7,394,607)  (5,150,881)
               Net property, plant
                and equipment               7,907,639    7,503,249

Other assets:
     Patents, net                           1,134,260      148,794
     Goodwill, net of accumulated
      amortization                          4,153,047    3,261,652
     Long-term investments                          0    1,299,545
     Notes receivable less
      current maturities                      373,160      383,080
     Deferred income taxes                  1,027,384            0
     Other                                          0      383,304
               Total other assets           6,687,851    5,476,375
                                          $53,399,790  $39,327,221
Liabilities and Stockholders' Equity

Current Liabilities:
     Current maturities of
      long-term debt                       $        0   $1,824,397
     Accounts payable                       4,796,373    3,869,521
     Accrued expenses                       2,136,361    1,374,635
     Accrued compensation expense
      and related costs                     2,030,112    1,448,928
     Accrued income tax expense             1,043,031      647,142
    Commissions payable and
     customer advances                        282,655      226,672
               Total current liabilities   10,288,532    9,391,295

Long-term debt, less current maturities             0    6,368,913
Deferred income taxes                               0       78,003
               Total liabilities           10,288,532   15,838,211

Stockholders' equity:
     Common stock                              85,517       67,785
     Additional paid-in capital            43,535,091   27,837,250
     Accumulated deficit                    (260,393)  (4,267,699)
     Cumulated translation adjustment       (100,631)            0
     Less: Notes receivable for
      common stock purchases                (148,326)     (148,326)

               Total stockholders' equity  43,111,258   23,489,010
                                          $53,399,790  $39,327,221




CONTACT: Applied Science and Technology, Inc.

John Tarrh, 781/937-5135

or

Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Contact:

Donna N. Stein Stein , William Howard 1911-1980.

American biochemist. He shared a 1972 Nobel Prize for pioneering studies of ribonuclease.
, APR/Dan Durkin/Keil Decker

Morgen-Walke Associates, Inc.

212/850-5600

Press Contact:Lee Foley/Elizabeth Pieroni

Morgen-Walke Associates, Inc.

212/850-5600
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 28, 1998
Words:1819
Previous Article:TimesTen Option Now Shipping With Prism's Executive Suite.
Next Article:Equity Marketing Secures $15 Million Promotion Contract.
Topics:



Related Articles
ASTEX ANNOUNCES RECORD THIRD QUARTER AND NINE MONTH REVENUES AND EARNINGS.
ASTeX Announces Fiscal 1997 First Quarter Revenues and Earnings.
ASTeX Announces Fiscal 1997 Third Quarter Results.
ASTeX Announces Record Fiscal 1998 Second Quarter Earnings.
ASTeX Announces Fiscal 1998 Fourth Quarter and Year End Financial Results.
ASTeX Announces Fiscal 1998 Fourth Quarter and Year End Financial Results.
ASTeX Announces Fiscal 1999 First Quarter Results.
AFMA revises sales projections.
ASTeX Announces Fiscal 2000 Second Quarter Results; Reports Third Consecutive All Time Record Quarterly Revenues and Earnings.
Maxim Reports Record Revenues and Earnings for the Fourth Quarter and Fiscal Year.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles